Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | LCK | P06239 | 1/20 | 0.32 |
| ▸ | FYN | P06241 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
| ▸ | RXRB | P28702 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4641028 | 1.00 | HSD17B10 (0.35) | HSD17B10TSHRL3MBTL1ALDH1A1SMN1; SMN2 | |
| SCHEMBL4641025 | 0.95 | L3MBTL1 (0.36) | TSHRL3MBTL1ALDH1A1SMN1; SMN2MEN1 | |
| SCHEMBL4640713 | 0.92 | HSD17B10 (0.39) | HSD17B10TSHRL3MBTL1ALDH1A1LCK | |
| SCHEMBL4640001 | 0.92 | SMN1; SMN2 (0.36) | HSD17B10TSHRALDH1A1SMN1; SMN2MEN1 | |
| SCHEMBL4644185 | 0.88 | ALDH1A1 (0.38) | HSD17B10TSHRL3MBTL1ALDH1A1MEN1 | |
| SCHEMBL4641359 | 0.88 | ALDH1A1 (0.38) | HSD17B10TSHRL3MBTL1ALDH1A1MEN1 | |
| SCHEMBL4640950 | 0.87 | HSD17B10 (0.35) | HSD17B10TSHRL3MBTL1ALDH1A1LCK | |
| SCHEMBL4640710 | 0.86 | L3MBTL1 (0.36) | HSD17B10TSHRL3MBTL1MEN1KMT2A | |
| SCHEMBL4639998 | 0.86 | GRM1 (0.36) | TSHRL3MBTL1ALDH1A1SMN1; SMN2MEN1 | |
| SCHEMBL4643639 | 0.86 | HSD17B10 (0.35) | HSD17B10TSHRL3MBTL1LCKFYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1188739-B1 | PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS | TOHO TITANIUM CO LTD (JP) | 2008-08-13 | — | — | EP | disclosed |
| US-6670497-B2 | Dialkyl (at least one of which is a C4-8 tertiary alkyl) ester of an alkyl- or halo-substituted phthalic acid; used in an olefin polymerization catalyst | TOHO TITANIUM CO., LTD. (JP) | 2003-12-30 | — | — | US | disclosed |
| US-20030036594-A1 | Phthalic diester derivatives and electron donors | TOHO TITANIUM CO., LTD. (JP) | 2003-02-20 | — | — | US | disclosed |
| EP-1188739-A1 | PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS | TOHO TITANIUM CO., LTD. (JP) | 2002-03-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030036594-A1 | Phthalic diester derivatives and electron donors | HPD, ETFA, PPOX | HSD17B10 117/4885TSHR 4817/4885L3MBTL1 4720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.